Synlogic, Inc. SEC filings SYBX
Synlogic, Inc. has 627 filings in SEC EDGAR's recent list, going back to Aug 23, 2011. Its latest annual report, Form 10-K, was filed on Mar 12, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jul 29, 2026 (material agreement, change to shareholder rights, change in control, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 425 | Filing | Nov 5, 2026 | — |
| 425 | Filing | Nov 2, 2026 | — |
| 425 | Filing | Jul 29, 2026 | — |
| 25-NSE | Delisting notice | May 18, 2026 | — |
| EFFECT | Filing | Aug 20, 2025 | — |
| CORRESP | Letter to the SEC | Aug 18, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 13, 2025 | — |
| 8-A12B | Filing | Feb 20, 2024 | — |
| EFFECT | Filing | Sep 28, 2023 | — |
| CORRESP | Letter to the SEC | Sep 26, 2023 | — |
| CORRESP | Letter to the SEC | Sep 26, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 25, 2023 | — |
| CORRESP | Letter to the SEC | Sep 20, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 15, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 11, 2023 | — |
| EFFECT | Filing | Jul 30, 2021 | — |
| CORRESP | Letter to the SEC | Jul 29, 2021 | — |
| UPLOAD | Letter from the SEC | Jul 28, 2021 | — |
| EFFECT | Filing | Sep 13, 2019 | — |
| CORRESP | Letter to the SEC | Sep 11, 2019 | — |
| CORRESP | Letter to the SEC | Aug 30, 2019 | — |
| UPLOAD | Letter from the SEC | Aug 20, 2019 | — |
| D | Filing | Jun 18, 2019 | — |
| CT ORDER | Filing | Apr 23, 2019 | — |
| CT ORDER | Filing | Dec 20, 2018 | — |
| EFFECT | Filing | Aug 30, 2018 | — |
| CORRESP | Letter to the SEC | Aug 28, 2018 | — |
| CORRESP | Letter to the SEC | Aug 23, 2018 | — |
| UPLOAD | Letter from the SEC | Aug 20, 2018 | — |
| EFFECT | Filing | Oct 25, 2017 | — |
| CORRESP | Letter to the SEC | Oct 23, 2017 | — |
| UPLOAD | Letter from the SEC | Oct 23, 2017 | — |
| CT ORDER | Filing | Sep 19, 2017 | — |
| EFFECT | Filing | Jul 13, 2017 | — |
| CORRESP | Letter to the SEC | Jul 11, 2017 | — |
| UPLOAD | Letter from the SEC | Jun 30, 2017 | — |
| 425 | Filing | Jun 9, 2017 | — |
| 425 | Filing | May 19, 2017 | — |
| 425 | Filing | May 17, 2017 | — |
| 425 | 8-k | May 16, 2017 | — |
| CT ORDER | Filing | Apr 13, 2017 | — |
| CT ORDER | Filing | Jul 11, 2016 | — |
| CT ORDER | Filing | Oct 1, 2015 | — |
| EFFECT | Filing | Sep 30, 2015 | — |
| CORRESP | Letter to the SEC | Sep 25, 2015 | — |
| CERTNAS | Auto-generated paper document | Sep 25, 2015 | — |
| 8-A12B | Filing | Sep 23, 2015 | — |
| CORRESP | Letter to the SEC | Sep 2, 2015 | — |
| CORRESP | Letter to the SEC | Aug 24, 2015 | — |
| UPLOAD | Letter from the SEC | Aug 13, 2015 | — |
| DRS/A | Filing | Jul 15, 2015 | — |
| D | Filing | May 1, 2015 | — |
| DRSLTR | Filing | May 13, 2014 | — |
| DRS/A | Filing | May 13, 2014 | — |
| UPLOAD | Letter from the SEC | May 6, 2014 | — |
| DRSLTR | Filing | Apr 22, 2014 | — |
| DRS/A | Filing | Apr 22, 2014 | — |
| UPLOAD | Letter from the SEC | Apr 9, 2014 | — |
| DRS/A | Filing | Apr 4, 2014 | — |
| DRS | Filing | Mar 12, 2014 | — |
| D | Filing | Nov 2, 2012 | — |
| D | Filing | Aug 23, 2011 | — |
Showing 62 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SYBX (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Winchester, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1527599
- Former names
- Mirna Therapeutics, Inc. (until Aug 25, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.